Advertisement

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81
All >

Deals > Norway & Iceland

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Norway or Iceland, or involving organisations from these countries.

Total search results: 118 | Ordered by Date (descending)
1 2  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
InstruNor–Fluidigm: investment, 202002 acquisition $7.2m with $5.2m in cash + $2m in stock 2020-02-26
Zelluna–Glycostem Therapeutics: cell therapy contract manufacturing, 201911– collab developm + supply of TCR-guided NK-cell therapies 2019-11-19
Themis Bioscience–Hadean Ventures: investment, 201909 financing round Series D totalling €40m incl new + co-lead investor Hadean Ventures 2019-09-18
OncoImmunity–NEC: investment, 201907 acquisition by NEC and renamed NEC OncoImmunity AS 2019-07-29
Yahong Meditech–Photocure: Cevira®, 201907– license ww developm + commercialisation to Asieris up to $250m milestones + royalties 2019-07-01
Saga Diagnostics–Hadean Ventures: investment, 201906 financing round totalling SEK40m (€3.7m) incl new + lead investor Hadean Ventures 2019-06-11
Zelluna–Image Box: public relations, 201810 supply service existent by Image Box PR 2018-10-24
Bavarian Nordic–PCI Biotech: PCI technology, 201808– collab research preclinical evaluation of integration of technologies from both companies 2018-08-20
IMMUNOMONITOR project–Ultimovacs: pharmacogenomics, 201807– collab partner in Eurostars project to develop validation treatm response cancer vaccines 2018-07-05
Immuneed–Ultimovacs: investment, 201807 acquisition NOK50.4m in cash + shares of TET Pharma cancer vaccine technology sub from Immuneed by Ultimovacs 2018-07-01
Ultimovacs–Immuneed: investment, 201807 acquisition 5.41% shareholding as part of compensation for sale of TET Pharma business to Ultimovacs 2018-07-01
Oculis–Brunnur Ventures: investment, 201801 financing round Series B totalling CHF20m incl existing + co-investor Brunnur Ventures 2018-01-04
Oculis–Silfurberg: investment, 201801 financing round Series B totalling CHF20m incl existing + co-investor Silfurberg 2018-01-04
Hadean Ventures–SEVERAL: investment, 201712 closing €100m of Hadean Capital I fund incl investors Argentum + Saminvest et al. 2017-12-18
NorthSea Therapeutics–BASF: icosabutate, 201712– license from Pronova BioPharma Norge AS 2017-12-12
BerGenBio–Huntsworth: public relations, 201708 service existent by Citigate Dewe Rogerson 2017-08-18
Lytix Biopharma–SEVERAL: investment, 201704 private placement NOK60m incl NOK6m from Norwegian Cancer Society 2017-04-20
BerGenBio–SEVERAL: investment, 201703–201704 IPO NOK400m with 16m new shares at NOK25/Share at Oslo Stock Exchange 2017-03-08
Bayer–Yara: digital farming, 201702– collab + license ww to ImageIT mobile imaging technology for plant monitoring + farming recommendations 2017-02-20
Vaccibody–SEVERAL: investment, 201612 private placement NOK220m (€24m) with 880k new shares at NOK250/share to new + existing investors 2016-12-09
Nordic Nanovector–SEVERAL: investment, 201612 private placement NOK498.7m ($59.3m) with 4.4m new shares at 114NOK/share 2016-12-07
Nordic Nanovector–Wilex: antibody-drug conjugates, 201610– collab developm of ADCs for leukemias with Heidelberg Pharma 2016-10-26
LegoChem–Nordic Nanovector: antibody-drug conjugates, 201610– collab to develop CD37-targeting ADCs for leukemias 2016-10-10
Oculis–SEVERAL: investment, 201608 financing round Series A led by Brunnur Ventures + Silfurberg 2016-08-11
Nordic Nanovector–Informa: investor conference, 201605 supply service Nordic Nanovector ASA presents at BioEquity Europe 2016 2016-05-11
Bayer–Holta Invest: investment, 201603 existent Bayer listed as portfolio company of Holta Life Sciences 2016-03-28
Biolink (NO)–Holta Invest: investment, 201603 existent Biolink Group listed as portfolio company of Holta Life Sciences 2016-03-28
Cempra–Holta Invest: investment, 201603 existent Cempra Inc listed as portfolio company of Holta Life Sciences 2016-03-28
Cortendo–Holta Invest: investment, 201603 existent Cortendo AB listed as portfolio company of Holta Life Sciences 2016-03-28
Mylan–Holta Invest: investment, 201603 existent Mylan listed as portfolio company of Holta Life Sciences 2016-03-28
OncoMed Pharmaceuticals–Holta Invest: investment, 201603 existent OncoMed listed as portfolio company of Holta Life Sciences 2016-03-28
PreTect–Holta Invest: investment, 201603 existent PreTect listed as portfolio company of Holta Life Sciences 2016-03-28
Roche–Holta Invest: investment, 201603 existent Roche listed as portfolio company of Holta Life Sciences 2016-03-28
BerGenBio–SEVERAL: investment, 201603 financing round NOK212m=$25m private placing to existing investors 2016-03-18
Biolink (NO)–Evonik: investment, 201603 acquisition €na of MedPalett AS by Evonik from Biolink Group 2016-03-03
Nordic Nanovector–Norway (govt): grant, 201602– BIA grant up to NOK15m over 3y from Research Council of Norway to develop ARCs 2016-02-01
Vaccibody–Norway (govt): grant, 201602– BIA grant up to NOK20m ($2.3m) over 4y from Research Council of Norway to develop cancer vaccines 2016-02-01
Nordic Nanovector–Informa: partnering conference, 201601 supply service Nordic Nanovector ASA presents at Biotech Showcase 2016 2016-01-13
Nordic Nanovector–Huntsworth: public relations, 201601 service existent media relations by Citigate Dewe Rogerson 2016-01-08
Lytix Biopharma–SEVERAL: investment, 201512 capital increase NOK80m w 224.2k new shares at NOK350/share to existent + new shareholders 2015-12-15
Alvogen–Insilico Biotechnology: bioinformatics, 201511– collab Alvotech using Insilico simulation s/w to develop biosimilars using mammalian cells 2015-11-27
JnJ–Nextera: phage display technology, 201509– collab research using Nextera technology platform in area of RA JnJ Innovation Centre London 2015-09-21
Nextera–Birk Venture: investment, 201509 existent by Birk Venture 2015-09-21
Nextera–Univ Oslo: investment, 201509 existent by Norwegian Radium Hospital Research Foundation 2015-09-21
Boehringer–Vectron Biosolutions: gene expression technology, 201509– license non-excl to Vectron technology for use w BI e. coli production system 2015-09-01
Oncos Therapeutics–Targovax: investment, 201506– merger 50/50 in shares ANNOUNCED to become Polaris 2015-06-11
Targovax–SEVERAL: investment, 201506– private placement to raise NOK125–150m + support merger w Oncos Therapeutics 2015-06-11
Univ Oslo–Medigene: DC vaccine, 201504 collab existent compassionate use in academic clinical studies in solid tumours by Oslo Univ Hospital 2015-04-20
Nordic Nanovector–SEVERAL: investment, 201503–201504 IPO NOK500m+NOK75m at Oslo Stock Exchange at NOK32/share 2015-03-20
Avexxin–Informa: partnering conference, 201501 supply service Avexxin AS presents at Biotech Showcase 2015 2015-01-12
Nordic Nanovector–Informa: partnering conference, 201501 supply service Nordic Nanovector AS presents at Biotech Showcase 2015 2015-01-12
PCI Biotech–Informa: partnering conference, 201501 supply service PCI Biotech AS presents at Biotech Showcase 2015 2015-01-12
Pre Diagnostics–Informa: partnering conference, 201501 supply service Pre Diagnostics AS presents at Biotech Showcase 2015 2015-01-12
Serodus–Informa: partnering conference, 201501 supply service Serodus ASA presents at Biotech Showcase 2015 2015-01-12
BerGenBio–FTI Consulting: public relations, 201412 service existent by FTI Consulting 2014-12-15
BerGenBio–SEVERAL: investment, 201412 financing round NOK90m=$15m private placing to new + existing investors 2014-12-15
Nordic Nanovector–SEVERAL: investment, 201408–201409 capital increase NOK50m (($7.8m) with 2m new shares at NOK25/share 2014-08-28
Revent Medical–Holta Invest: investment, 201406 investment by Holta Life Sciences 2014-08-06
Weifa–Holta Invest: investment, 201408 investment by Holta Life Sciences 2014-08-06
International Council of Biotechnology Associations–Norwegian Bioindustry Association: biotechnology, 201407 NBA is founding member of ICBA 2014-07-10
Nordic Nanovector–Holta Invest: investment, 201407 investment by Holta Life Sciences 2014-07-01
BerGenBio–SEVERAL: investment, 201402 financing round NOK75m=$12.5m from new + existing investors 2014-02-04
Lytix Biopharma–SEVERAL: investment, 201312 capital increase NOK50m 2013-12-04
Algeta–Bayer: investment, 201311– acquisition proposal by Bayer NOK362/share valuing Algeta equity at €2.1b 2013-11-26
Vaccibody–SEVERAL: investment, 201306 private placement €733k to existing investors 2013-06-21
CellCura–SEVERAL: investment, 201306 private placement NOK8.4m 41.7m shares at NOK0.2/share 2013-06-13
DiaGenic–Life Technologies: Thermocycler, 201306 supply acquisition of QuantStudio Dx instruments by DiaGenic 2013-06-05
BerGenBio–SEVERAL: investment, 201305 financing round $6m from existing investors 2013-05-26
Serodus–SEVERAL: investment, 201303 IPO €0.5m at Oslo Stock Exchange 2013-03-25
DiaGenic–SEVERAL: investment, 201303 private placement NOK30m 50m new shares NOK0.60/share 2013-02-15
Guangzhou Haoxin Instrument–CellCura: in viro fertilization technology, 201308 distribution existent in China by Haoxin 2013-01-17
deCode–Amgen: investment, 201212 acquisition $415m in cash ANNOUNCED 2012-12-10
Ablynx–Algeta: cancer drugs, 201211– collab research to evaluate thorium-227 alpha-pharmaceutical with Nanobodies to treat cancer 2012-11-21
Pronova BioPharma–BASF: investment, 201211–201301 public cash offer NOK4.996b=€684m NOK13.5/share by BASF AS 2012-11-21
BerGenBio–Telenor: investment, 201210 existent Norsk Innovasjonskapital II AS owns 13.71% 2012-10-27
Genetic Analysis (NO)–Telenor: investment, 201210 existent Norsk Innovasjonskapital AS owns 89.41% 2012-10-27
APIM Therapeutics–SEVERAL: investment, 201210 financing round led by Norsk Innovasjonskapital III AS 2012-10-17
APIM Therapeutics–Telenor: investment, 201210 financing round led by Norsk Innovasjonskapital III AS resulting 26.3% share 2012-10-17
BerGenBio–Sygnature Discovery: drug development services, 201210– supply service pre-clinical developm of small molecule BGB002 2012-10-08
Vaccibody–SEVERAL: investment, 201207 capital increase €875k issue of new shares to Sarsia Seed et al. 2012-07-30
DiaGenic–Norway (govt): grant, 201205 BIA funds grant NOK7.8m from Norwegian Research Council for blood based Alzheimer diagnostic product developm 2012-05-15
Actavis–Watson: investment, 201204–201210 acquisition €4.15b in cash + milestone-based issue of up to 5.5m common shares (approx €250m) 2012-04-25
Univ Oslo–Thermo Fisher: mass spectrometer, 201203 supply Q-Exactive Orbitrap MS to Bioanalytics@UiO for proteomics + metabolomics applications 2012-03-28
Actavis–Bioton: insulin products, 201201– collab + jv €55.5m with €22.25m upfront developm + production by Bioton + sales in Europe + US by Actavis 2012-01-30
Targovax–SEVERAL: investment, 201201 financing round Series A NOK13m=$2.2m from Radium Hospital + Birk Venture + RO Invest + existing owners 2012-01-25
Clavis Pharma–SEVERAL: investment, 201201 private placement NOK163m 2.86m new shares NOK53/share 2012-01-17
BerGenBio–SEVERAL: investment, 201201 financing round Series A $8.8m lead investors Sarsia Seed AS + Investinor AS 2012-01-04
Matriks–Agilent: analytical instruments, 201112 distribution existent Matriks is authorized Agilent reseller in Norway 2011-12-09
Matriks–Parker Hannifin: gas generator, 201112 distribution existent of Parker Balston gas generators in Norway 2011-12-09
BerGenBio–Publicis: public relations, 201110 service existent by Schwartz Communications 2011-10-31
BerGenBio–Rigel: AXL inhibitor, 201110 license existent to BGB324 2011-10-31
Univ Bergen–Agilent: mass spectrometer, 201109 supply existent LC-ChipCube-MSD XCT Ion Trap listed on PROBE web site 2011-09-11
Univ Bergen–Danaher: mass spectrometer, 201109 supply existent AB Sciex 4000 Qtrap LC-MSMS listed on PROBE web site 2011-09-11
Univ Bergen–Danaher: mass spectrometer, 201109 supply existent AB Sciex 5500 Qtrap LC-MSMS listed on PROBE web site 2011-09-11
Univ Bergen–Thermo Fisher: liquid chromatography, 201109 supply existent Dionex UltiMate 3000 offline HPLC listed on PROBE web site 2011-09-11
Univ Bergen–Thermo Fisher: mass spectrometer, 201109 supply existent Orbitrap Velos Pro listed on PROBE web site 2011-09-11
Clavis Pharma–Skyline Diagnostics: molecular companion diagnostics, 201109– collab developm gene expression biomarker panel for elacytarabine for AML 2011-09-06
Cardiac Assist–NeoMed: investment, 201108 existent listed as portfolio company on NeoMed web site 2011-08-13
Diagnoplex–NeoMed: investment, 201108 existent listed as portfolio company on NeoMed web site 2011-08-13
EndoSense–NeoMed: investment, 201108 existent listed as portfolio company on NeoMed web site 2011-08-13
1 2  next pagenext page



Advertisement

Picture [iito] Plain Stupid Simple 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

» top